Fixed-dose Combinations

Once-daily Boosted Fosamprenavir or Atazanavir in Treatment-naive Patients: The ALERT Study   10/06/06

Fixed-dose Abacavir/3TC Administered Once-daily Compared with Separate Components Twice-daily: The ALOHA Study   10/06/06

Trizivir versus Unboosted Atazanavir/AZT/3TC: The ACTION Study   10/03/06









Google_______________



 

 

 

 



 

 

 

 

 


Conference
Main Page